ask="9.95"
ask_size="100"
average_daily_volume="166303"
bid="4.15"
bid_size="100"
book_value="7.07"
change="+0.13"
change_from_200_day_moving_average="6.46"
change_from_50_day_moving_average="3.33"
change_from_52_week_high="-4.70"
change_From_52_week_low="3.00"
change_in_percent="+1.45%"
close="9.10"
dividend_pay_date="6/27/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.47"
ebitda="-15.57M"
eps_estimate_current_year="-3.65"
eps_estimate_next_quarter="-0.75"
eps_estimate_next_year="-2.10"
ex_dividend_date="6/28/2013"
float_shares="7983000"
high="9.25"
high_52_weeks="13.80"
last_trade_date="1/17/2017"
last_trade_price="9.10"
last_trade_size="200"
last_trade_time="4:00pm"
low="8.80"
low_52_weeks="6.10"
market_capitalization="96.14M"
moving_average_200_day="2.64"
moving_average_50_day="5.77"
name="Novelion Therapeutics Inc."
notes="N/A"
one_year_target_price="13.50"
open="8.90"
pe_ratio="N/A"
peg_ratio="0.16"
percent_change_from_200_day_moving_average="+245.14%"
percent_change_from_50_day_moving_average="+57.65%"
percent_change_from_52_week_high="-34.06%"
percent_change_from_52_week_low="+49.18%"
previous_close="8.97"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.27"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="10565000"
short_ratio="1.23"
stock_exchange="NMS"
symbol="NVLN"
volume="62909"
weeks_range_52="6.10 - 13.80"
